Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-11 Purchase | 2023-12-12 08:26 am | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 6,455 | $6.8523 | $44,232 | 4,559,233 (Indirect) | View |
| 2023-12-07 Purchase | 2023-12-11 5:25 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 127,549 | $6.9809 | $890,411 | 4,552,778 (Indirect) | View |
| 2023-11-29 Purchase | 2023-12-01 5:14 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 51,837 | $5.9702 | $309,477 | 4,425,229 (Indirect) | View |
| 2023-11-27 Purchase | 2023-11-29 5:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 93,187 | $5.5941 | $521,294 | 4,373,392 (Indirect) | View |
| 2023-05-15 Purchase | 2023-05-17 5:07 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 101,740 | $9.6462 | $981,404 | 4,280,205 (Indirect) | View |
| 2021-06-10 Sale | 2021-06-11 5:00 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 11,229 | $36.15 | $405,971 | 4,178,465 (Indirect) | View |
| 2021-06-08 Sale | 2021-06-10 6:35 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 150,000 | $35.99 | $5,397,810 | 4,189,694 (Indirect) | View |
| 2021-06-07 Sale | 2021-06-09 6:49 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 72,400 | $34.15 | $2,472,583 | 4,339,694 (Indirect) | View |
| 2021-06-03 Sale | 2021-06-07 4:31 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 34,507 | $33.28 | $1,148,373 | 4,412,094 (Indirect) | View |
| 2021-05-28 Sale | 2021-06-02 4:32 pm | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 31,864 | $36.17 | $1,152,648 | 4,446,601 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-11 Option Award | 2024-06-13 9:01 pm | N/A 2034-06-11 | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director 10% Owner | 18,040 | $0 | 4,579,603 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:04 pm | N/A 2033-06-08 | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 16,280 | $0 | 4,296,485 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 1:23 pm | N/A 2032-07-14 | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:05 pm | 2021-07-10 2031-06-10 | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-03-10 Other | 2021-03-12 4:40 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 1,029,927 | $0 | 5,508,392 (Indirect) | View |
| 2020-06-23 Option Award | 2020-06-24 4:48 pm | 2020-07-23 2030-06-23 | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2019-12-30 Other | 2019-12-31 4:05 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director | 498,392 | $0 | 6,505,176 (Indirect) | View |